Characterization of Gαs and Gαolf activation by catechol and non-catechol dopamine D1 receptor agonists
The dopamine D1 receptor (D1R) couples to Gα<sub>s</sub> and Gα<sub>olf</sub> and is crucial in regulating neurological and neuropsychiatric functions. In the brain, Gα<sub>olf</sub> is predominantly found in the striatum whereas Gα<sub>s</sub> is expressed elsewhere. Our <i>in vitro</i> assays revealed that the tetracyclic catechol agonists dihydrexidine, methyl-dihydrexidine, doxanthrine, and the non-catechol compounds PF-8294, PF-6142 exerted full agonism for Gα<sub>s</sub> coupling but only partial agonism for Gα<sub>olf</sub> coupling. In contrast, the non-catechol agonist tavapadon acted as a full agonist at Gα<sub>olf</sub> and a partial agonist at Gα<sub>s</sub>. The effects of these ligands on the thalamocortical and striatonigral electrophysiological events, as well as on the locomotor activity and cognitive function of mice agreed with their selectivity profiles <i>in vitro</i>. These findings suggest the possibility of achieving region-specific pharmacology and open new directions for developing D1R drugs to treat relevant neurological and neuropsychiatric disorders.
Authors
- Asuka Inoue (ORCID: https://orcid.org/0000-0003-0805-4049)
- Hideaki Yano (ORCID: https://orcid.org/0000-0001-9242-3884)
- Ana Semeano (ORCID: https://orcid.org/0000-0002-6995-2072)
- Anh Minh Nguyen (ORCID: https://orcid.org/0009-0001-7754-4167)
- David E. Nichols
- Vianna Quach
Institutions
- University of North Carolina at Chapel Hill (US)
- Northeastern University (US)
- Tohoku University (JP)
Publication Details
- Journal
- iScience
- Published
- 2025-04-04
- DOI
- https://doi.org/10.1016/j.isci.2025.112345
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.59
Funders
- Northeastern University